TNF and prostate cancer: Results of various other studies also show that, relative to normal healthy controls, a significant increase in circulating levels of TNF-α was observed in hepatocellular carcinoma patients [21], cervical neoplasia [22, 23], epithelial ovarian cancer [24, 25], prostate cancer [26], and renal cell carcinoma [27].